PDFprof.comSearch Engine CopyRight

Second-line chemotherapy for ovarian cancer


Topotecan. After platinum and paclitaxel, topotecan is the agent that has undergone the most extensive testing to define a role as second-line therapy for recurrent ovarian cancer [19, 20], and has been approved by the U.S. Food and Drug Administration (FDA) for that indication.

Is Second-Line chemo Effective?

Second-line treatment often works very well for certain types of cancer. People with other types of cancer may have only a small chance that second-line treatment will work. Other factors that affect whether second-line therapy may work include: The stage of the cancer.

What are the two most common chemotherapy to treat ovarian cancer?

You might have chemotherapy after surgery, or both before and after. Doctors often use the drugs carboplatin and paclitaxel for ovarian cancer.

What is the line of treatment for ovarian cancer?

In general, chemotherapy is recommended for all women who are newly diagnosed with ovarian cancer, except in the case of selected women with stage IA or IB disease (also called "early-stage disease"), in which case surgery alone is often effective. Women with later-stage disease are offered chemotherapy.

What is second-line therapy cancer?

Second-line treatment is treatment for a disease or condition after the initial treatment (first-line treatment) has failed, stopped working, or has side effects that aren't tolerated. It's important to understand "lines of treatment" and how they differ from first line treatment and can play a role in clinical trials.




[PDF] Second-line carboplatin and gemcitabine in platinum sensitive

Second-line carboplatin and gemcitabine in platinum sensitive www sciencedirect com/science/article/pii/S0923753419542338/ md5=44d7ac305d320111336439cc87cb2883&pid=1-s2 0-S0923753419542338-main pdf Despite the progress which has been achieved by intro- ducing platinum-paclitaxel combination chemotherapy into first-line treatment of advanced ovarian cancer

[PDF] Low response rate of second-line chemotherapy for recurrent or

Low response rate of second-line chemotherapy for recurrent or ijgc bmj com/content/ijgc/18/5/937 full pdf apy for recurrent or refractory clear cell carcinoma of the ovary: a tumor 4) at least two cycles of second-line chemotherapy and assessable for the

[PDF] The role of anthracyclines in second-line therapy of ovarian cancer

The role of anthracyclines in second-line therapy of ovarian cancer ijgc bmj com/content/ijgc/13/Suppl_2/178 full pdf All these latter trials suggest that the choice of drugs for second-line treatment and whether we give single agents or combination chemotherapy to subsets of

[PDF] Salvage therapy for recurrent epithelial ovarian cancer

Salvage therapy for recurrent epithelial ovarian cancer cbc br/wp-content/uploads/2013/07/072009-HOCNA2 pdf Doyle et al [53] 42 of women with recurrent ovarian cancer receiving second- line and third-line salvage therapy thought that chemotherapy would have a



[PDF] Evidence-based chemotherapeutic management of potentially

Evidence-based chemotherapeutic management of potentially www openaccessjournals com/articles/evidencebased-chemotherapeutic-management-of-potentially-platinumsensitive-recurrent-ovarian-cancer pdf accompany second-line ovarian cancer treat- ment and the cost to the patient Platinum versus nonplatinum chemotherapy in recurrent ovarian cancer

[PDF] Survival impact of extended cycles of second-line chemotherapy in

Survival impact of extended cycles of second-line chemotherapy in bmccancer biomedcentral com/track/ pdf /10 1186/s12885-020-07658-8 pdf second-line chemotherapy in platinum- sensitive relapsed ovarian cancer patients with residual tumor after six cycles Se Ik Kim1† Woo Yeon Hwang2†

    Second-line drug meaning

    Second-line treatment colorectal cancer

    Second-line treatment meaning